Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ Serum Institute of India pneumonia vaccine ]

Results 1 to 11 of 11
BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


PTI
December 24, 2020
India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
October 22, 2020
There is not a single instance in history of a vaccine that has been discontinued


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


PTI
July 16, 2020
The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India


BusinessToday.In
July 9, 2020
Coronavirus myths: Thanks to the potent combination of social media and mischief-makers, there are an endless number of myths floating around on COVID-19


PB Jayakumar
April 5, 2020
India's Zydus Cadila, Serum Institute and Bharat Biotech are among the global firms working on COVID-19 vaccine


PTI
October 23, 2018



E Kumar Sharma
August 26, 2014
For the moment, the focus in India is largely to screen people entering the country from the airports and ports, mainly from Africa. It is largely on self-reporting by passengers travelling to India, followed by screening.


E. Kumar Sharma
August 5, 2010
India becomes a hot market for optional vaccines.


PAGES 1 OF 1